DrugPatentWatch Database Preview
Drugs in Development Information for Favipiravir
Drug Development Status for Favipiravir: Patents, clinical trial progress, indications
Favipiravir is an investigational drug.
There have been 8 clinical trials for Favipiravir.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2014.
The most common disease conditions in clinical trials are Influenza, Human, Hemorrhagic Fever, Ebola, and Virus Diseases. The leading clinical trial sponsors are MDVI, LLC, Institut National de la Santé Et de la Recherche Médicale, France, and MediVector, Inc.
There are fifteen US patents protecting this investigational drug and two hundred and eighty-six international patents.
Summary for Favipiravir
| US Patents | 15 |
| International Patents | 286 |
| US Patent Applications | 35 |
| WIPO Patent Applications | 35 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2014-01-01) |
| Vendors | 75 |
Recent Clinical Trials for Favipiravir
| Title | Sponsor | Phase |
|---|---|---|
| Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 |
| Efficacy of Favipiravir Against Ebola (JIKI) | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 |
| Efficacy of Favipiravir Against Severe Ebola Virus Disease | 307 Hospital of PLA | Phase 2 |
Clinical Trial Summary for Favipiravir
Top disease conditions for Favipiravir
Top clinical trial sponsors for Favipiravir
US Patents for Favipiravir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Favipiravir | Start Trial | Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same | Toyama Chemical Co., Ltd. (Tokyo, JP) | Start Trial |
| Favipiravir | Start Trial | Pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof | Toyama Chemical Co., Ltd. (Tokyo, JP) | Start Trial |
| Favipiravir | Start Trial | Compositions and kits for treating influenza | Adamas Pharmaceuticals, Inc. (Emeryville, CA) | Start Trial |
| Favipiravir | Start Trial | Compositions and kits for treating influenza | Adamas Pharmaceuticals, Inc. (Emeryville, CA) | Start Trial |
| Favipiravir | Start Trial | Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same | Toyama Chemical Co., Ltd. (Tokyo, JP) | Start Trial |
| Favipiravir | Start Trial | Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide | Toyama Chemical Co., Ltd. (Tokyo, JP) | Start Trial |
| Favipiravir | Start Trial | Method for producing dichloropyrazine derivative | Nippon Soda Co., Ltd. (Tokyo, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Favipiravir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Favipiravir | Austria | 376418 | 2018-08-20 | Start Trial |
| Favipiravir | Australia | 5300499 | 2018-08-20 | Start Trial |
| Favipiravir | Australia | 756635 | 2018-08-20 | Start Trial |
| Favipiravir | Brazil | 9913097 | 2018-08-20 | Start Trial |
| Favipiravir | Canada | 2339272 | 2018-08-20 | Start Trial |
| Favipiravir | China | 1154493 | 2018-08-20 | Start Trial |
| Favipiravir | China | 1275947 | 2018-08-20 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
